94 related articles for article (PubMed ID: 1523167)
1. Uptake and metabolism of [3H]-Leu-enkephalin following either its intraperitoneal or subcutaneous administration to mice.
Janak PH; Schulteis G; Martinez JL
Peptides; 1992; 13(3):551-5. PubMed ID: 1523167
[TBL] [Abstract][Full Text] [Related]
2. Plasma uptake and in vivo metabolism of [Leu]enkephalin following its intraperitoneal administration to rats.
Schulteis G; Weinberger SB; Martinez JL
Peptides; 1989; 10(5):913-9. PubMed ID: 2691996
[TBL] [Abstract][Full Text] [Related]
3. [Leu]enkephalin enhances active avoidance conditioning in rats and mice.
Janak PH; Manly JJ; Martinez JL
Neuropsychopharmacology; 1994 Feb; 10(1):53-60. PubMed ID: 8179794
[TBL] [Abstract][Full Text] [Related]
4. Oral delivery of mouse [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, in male Swiss Webster mice: a study comparing the pharmacokinetics of oral delivery to intraperitoneal, subcutaneous, intramuscular, and intranasal administration.
Lee DW; Leinung MC; Grasso P
Regul Pept; 2010 Feb; 160(1-3):129-32. PubMed ID: 20026361
[TBL] [Abstract][Full Text] [Related]
5. Hydrolysis of [Leu]enkephalin by chick plasma in vitro.
Shibanoki S; Weinberger SB; Beniston D; Nudelman KA; Schulteis G; Bennett EL; Rosenzweig MR; Ishikawa K; Martinez JL
J Pharmacol Exp Ther; 1991 Feb; 256(2):650-5. PubMed ID: 1994000
[TBL] [Abstract][Full Text] [Related]
6. Intranasal administration of mouse [D-Leu-4]OB3, a synthetic peptide amide with leptin-like activity, enhances total uptake and bioavailability in Swiss Webster mice when compared to intraperitoneal, subcutaneous, and intramuscular delivery systems.
Novakovic ZM; Leinung MC; Lee DW; Grasso P
Regul Pept; 2009 Apr; 154(1-3):107-11. PubMed ID: 19344673
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of nasal absorption of drugs. IV: Plasma levels of radioactivity following intranasal administration of [3H]leucine enkephalin.
Faraj JA; Hussain AA; Aramaki Y; Iseki K; Kagoshima M; Dittert LW
J Pharm Sci; 1990 Sep; 79(9):768-70. PubMed ID: 2273455
[TBL] [Abstract][Full Text] [Related]
8. Hepatic inactivation of Leu-enkephalin.
MacKinnon KL; Zuzel KA; Billington D
Regul Pept; 1996 Dec; 67(2):85-92. PubMed ID: 8958578
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary metabolism of exogenous enkephalins in isolated perfused rat lungs.
Gillespie MN; Krechniak JW; Crooks PA; Altiere RJ; Olson JW
J Pharmacol Exp Ther; 1985 Mar; 232(3):675-81. PubMed ID: 2983067
[TBL] [Abstract][Full Text] [Related]
10. Blood-brain barrier permeability to leucine-enkephalin, D-alanine2-D-leucine5-enkephalin and their N-terminal amino acid (tyrosine).
Zlokovic BV; Begley DJ; Chain-Eliash DG
Brain Res; 1985 Jun; 336(1):125-32. PubMed ID: 3891014
[TBL] [Abstract][Full Text] [Related]
11. Transport of leucine-enkephalin across the blood-brain barrier in the perfused guinea pig brain.
Zloković BV; Lipovac MN; Begley DJ; Davson H; Rakić L
J Neurochem; 1987 Jul; 49(1):310-5. PubMed ID: 3585338
[TBL] [Abstract][Full Text] [Related]
12. Replacement of the peptide-backbone amides connecting Tyr-Gly and Gly-Gly in leucine-enkephalin with ketomethylene groups: synthesis and biological activity.
Almquist RG; Olsen CM; Uyeno ET; Toll L
J Med Chem; 1984 Feb; 27(2):115-20. PubMed ID: 6319699
[TBL] [Abstract][Full Text] [Related]
13. Only tyrosine-containing metabolites of [Leu]enkephalin impair active avoidance conditioning in mice.
Janak PH; Martinez JL
Pharmacol Biochem Behav; 1990 Dec; 37(4):655-9. PubMed ID: 2093169
[TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatographic analysis of pulmonary metabolites of Leu- and Met-enkephalins in isolated perfused rat lung.
Crooks PA; Krechniak JW; Olson JW; Gillespie MN
J Pharm Sci; 1985 Sep; 74(9):1010-2. PubMed ID: 4067842
[TBL] [Abstract][Full Text] [Related]
15. Distribution of radioactivity in the spinal cord after intracerebroventricular and intravenous injection of radiolabeled opioid peptides in mice.
Ohlsson AE; Fu TC; Jones D; Martin BR; Dewey WL
J Pharmacol Exp Ther; 1982 May; 221(2):362-7. PubMed ID: 6281413
[TBL] [Abstract][Full Text] [Related]
16. Hydrolysis of leucine enkephalin in the nasal cavity of the rat--a possible factor in the low bioavailability of nasally administered peptides.
Hussain A; Faraj J; Aramaki Y; Truelove JE
Biochem Biophys Res Commun; 1985 Dec; 133(3):923-8. PubMed ID: 4084310
[TBL] [Abstract][Full Text] [Related]
17. H-Pro-[3H]Leu-Gly-NH2: plasma profile and brain uptake following subcutaneous injection in the rat.
Verhoef J; Prins A; Veldhuis HD; Witter A
J Neurochem; 1982 Apr; 38(4):1135-8. PubMed ID: 6121002
[TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of leucine-enkephalin cellular uptake at the luminal side of the blood-brain barrier of an in situ perfused guinea-pig brain.
Zlokovic BV; Mackic JB; Djuricic B; Davson H
J Neurochem; 1989 Nov; 53(5):1333-40. PubMed ID: 2795003
[TBL] [Abstract][Full Text] [Related]
19. Enkephalin hydrolysis by mouse plasma in vitro.
Shibanoki S; Weinberger SB; Schulteis G; Ishikawa K; Martinez JL
Life Sci; 1992; 50(10):667-75. PubMed ID: 1346713
[TBL] [Abstract][Full Text] [Related]
20. Absorption of alpha-MSH from subcutaneous and intraperitoneal sites in the rat.
Wright A; Wilson JF
Peptides; 1983; 4(1):5-9. PubMed ID: 6866809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
